title: [Effect of cavinton on the hemorheological parameters of chronic cerebrovascular patients].
authors.forename: L
authors.initials: L
authors.lastname: Sapary
authors.forename: B
authors.initials: B
authors.lastname: Horvath
authors.forename: T
authors.initials: T
authors.lastname: Alexy
authors.forename: Zs
authors.initials: Z
authors.lastname: Marton
authors.forename: G
authors.initials: G
authors.lastname: Kesmarky
authors.forename: M
authors.initials: M
authors.lastname: Zsots
authors.forename: F
authors.initials: F
authors.lastname: Nagy
authors.forename: I
authors.initials: I
authors.lastname: Czopf
authors.forename: K
authors.initials: K
authors.lastname: Toth
mesh_terms: D001809:Blood Viscosity / Q000187:drug effects*; D002560:Cerebrovascular Circulation / Q000187:drug effects / Q000502:physiology; D002561:Cerebrovascular Disorders / Q000097:blood* / Q000188:drug therapy / Q000503:physiopathology; D002908:Chronic Disease; D004903:Erythrocyte Aggregation / Q000187:drug effects*; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D005500:Follow-Up Studies; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D014748:Vinca Alkaloids / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D018696:Neuroprotective Agents; D014748:Vinca Alkaloids; C013983:vinpocetine; D005340:Fibrinogen